Quantum BioPharma Ltd. (CSE:QNTM)
Canada
· Delayed Price · Currency is CAD 7.40
+1.31 (21.51%)
At close: Apr 28, 2026
Quantum BioPharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -26.18 | -14.2 | -17.9 | -23.61 | -35.29 | Upgrade
|
| Depreciation & Amortization | 0.55 | 0.49 | 2.51 | 4.53 | 4.05 | Upgrade
|
| Other Amortization | 1.49 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.12 | - | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 4.56 | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -0.43 | 0 | 0.38 | 0.23 | 0.86 | Upgrade
|
| Stock-Based Compensation | 2.95 | 0.15 | 3.84 | 1.53 | 7.44 | Upgrade
|
| Other Operating Activities | 11.29 | -3.08 | -5.84 | -2.76 | 0.68 | Upgrade
|
| Change in Accounts Receivable | 0.2 | -0.15 | 0.16 | 0.22 | -0.11 | Upgrade
|
| Change in Inventory | 0.07 | -0.12 | - | - | - | Upgrade
|
| Change in Accounts Payable | 1.18 | 4.27 | 2.05 | -0.7 | 3.6 | Upgrade
|
| Change in Unearned Revenue | -1 | 1 | - | - | - | Upgrade
|
| Change in Other Net Operating Assets | 1.54 | 4.75 | -0.57 | -6.64 | -0.61 | Upgrade
|
| Operating Cash Flow | -8.24 | -6.88 | -10.83 | -28.33 | -20.75 | Upgrade
|
| Capital Expenditures | - | - | - | -0.11 | - | Upgrade
|
| Cash Acquisitions | - | - | 0.03 | - | 0.77 | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | -0.25 | -0.5 | Upgrade
|
| Investment in Securities | 1.18 | -0.5 | -0.74 | -0.24 | - | Upgrade
|
| Other Investing Activities | -3.13 | -1 | 0.44 | 12.73 | - | Upgrade
|
| Investing Cash Flow | -1.95 | -1.5 | -0.27 | 12.12 | 0.27 | Upgrade
|
| Short-Term Debt Issued | 2.11 | 0.31 | - | - | - | Upgrade
|
| Long-Term Debt Issued | 3.24 | 0.7 | - | - | - | Upgrade
|
| Total Debt Issued | 5.36 | 1.01 | - | - | - | Upgrade
|
| Short-Term Debt Repaid | -1.5 | - | - | - | -0.07 | Upgrade
|
| Long-Term Debt Repaid | -0.11 | -0.06 | -0.19 | -0.14 | -0.06 | Upgrade
|
| Total Debt Repaid | -1.61 | -0.06 | -0.19 | -0.14 | -0.13 | Upgrade
|
| Net Debt Issued (Repaid) | 3.75 | 0.95 | -0.19 | -0.14 | -0.13 | Upgrade
|
| Issuance of Common Stock | 0.53 | 10.67 | 0.02 | - | 38.34 | Upgrade
|
| Repurchase of Common Stock | - | - | -2.96 | -1.93 | - | Upgrade
|
| Other Financing Activities | 1.82 | - | - | - | - | Upgrade
|
| Financing Cash Flow | 6.1 | 11.62 | -3.13 | -2.07 | 38.21 | Upgrade
|
| Net Cash Flow | -4.09 | 3.24 | -14.22 | -18.28 | 17.73 | Upgrade
|
| Free Cash Flow | -8.24 | -6.88 | -10.83 | -28.45 | -20.75 | Upgrade
|
| Free Cash Flow Per Share | -2.51 | -6.05 | -17.78 | -47.74 | -38.59 | Upgrade
|
| Levered Free Cash Flow | -6.83 | -5.13 | -15.51 | -2.75 | -8.19 | Upgrade
|
| Unlevered Free Cash Flow | -7 | -5.1 | -15.51 | -2.72 | -8.15 | Upgrade
|
| Change in Working Capital | 1.99 | 9.76 | 1.64 | -7.12 | 2.89 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.